This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Surgery  • Cardiovascular/ Cardiothoracic Surgery  • Revascularization  • Alert me on articles by topic

Ruxana T. Sadikot, MD; Jeffrey T. Rogers, RRT; Dong-sheng Cheng, MD; Philip Moyers, MD; Michael Rodriguez, MD; Richard W. Light; for the Cardiovascular Surgery Associates PC

Arch Intern Med. 2000;160:2665-2668.

Background  This study describes the pleural fluid characteristics of patients who develop symptomatic pleural effusions after coronary artery bypass graft surgery (CABG).

Methods  Post-CABG patients who underwent a therapeutic thoracentesis for a symptomatic pleural effusion were included unless another explanation for the pleural effusion was present.

Results  During the study, 71 patients (mean age, 61 years) were identified; 49 were men and 22 were women. All patients underwent internal mammary artery grafting. Early effusions (<30 days after CABG) occurred in 45 patients (63%) and late effusions (30 days after CABG) developed in 26 (37%). Early effusions were bloody (median red blood cell count, 706 x 10¹²/L [706,000 mm³])with a high eosinophil count (median, 0.385), whereas effusions that occurred in the late period were yellow exudates with predominant lymphocytes (median, 0.68) and monocytes (median, 0.20). The mean pleural fluid level of lactate dehydrogenase was more than 3 times the upper limit of the reference range in serum in early effusions, whereas late effusions had significantly lower lactate dehydrogenase levels.

Conclusions  Characteristics of early and late effusions differ significantly, suggesting a different pathogenesis of the effusions. Patients who develop a symptomatic pleural effusion after CABG should undergo a therapeutic thoracentesis; however, further investigations are warranted only in patients who have pleural fluid characteristics different from those described.

From the Department of Medicine, Vanderbilt University (Drs Sadikot and Light), and Departments of Medicine (Mr Rogers and Drs Cheng, Moyers, Rodriguez, and Light) and Surgery (Dr Light and Cardiovascular Surgery Associates PC), Saint Thomas Hospital, Nashville, Tenn.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pleural Effusion After Ventricular Assist Device Placement: Prevalence and Pleural Fluid Characteristics
Guha et al.
Chest 2008;134:382-386.
ABSTRACT | FULL TEXT  

Eotaxin-3 and Interleukin-5 Pleural Fluid Levels Are Associated With Pleural Fluid Eosinophilia in Post-Coronary Artery Bypass Grafting Pleural Effusions
Kalomenidis et al.
Chest 2005;127:2094-2100.
ABSTRACT | FULL TEXT  

Metastatic Renal Cell Carcinoma-Associated Pleural Effusion After Coronary Artery Bypass Grafting
Rowlands et al.
JAOA: Journal of the American Osteopathic Association 2004;104:215-217.
ABSTRACT | FULL TEXT  

Prevalence and Clinical Course of Pleural Effusions at 30 Days after Coronary Artery and Cardiac Surgery
Light et al.
Am. J. Respir. Crit. Care Med. 2002;166:1567-1571.
ABSTRACT | FULL TEXT  

Pleural Effusion
Light
NEJM 2002;346:1971-1977.
FULL TEXT